Innate immune receptors sensing mRNA-lipid nanoparticle components (mRNA-LNP sensing receptors)

Innate immune receptors sensing mRNA-lipid nanoparticle (LNP) components are a collective group of pattern recognition receptors (PRRs) that detect the various elements of mRNA-based therapeutics and vaccines. This group primarily includes endosomal Toll-like receptors (TLR3, TLR7, and TLR8) and cytosolic sensors such as RIG-I and MDA5, which recognize the mRNA payload, as well as potential sensors for the ionizable lipid components of the LNP carrier. The biological function of these receptors is to initiate the innate immune response, which serves as a critical adjuvant effect for vaccines by promoting the maturation of antigen-presenting cells and the production of Type I interferons and pro-inflammatory cytokines (PubMed: 33674858, 34697316). In a clinical context, the activation of these receptors is essential for the efficacy of mRNA vaccines like those developed for COVID-19, but excessive or uncontrolled activation can lead to adverse effects such as systemic inflammation, fever, or rare complications like myocarditis. Therapeutic strategies often involve modifying the mRNA (e.g., using N1-methylpseudouridine) to reduce unintended sensing by TLR7 and TLR8, thereby improving the safety profile and translation efficiency of the mRNA (PubMed: 16111635). Understanding the interplay between these receptors and mRNA-LNP components is vital for the development of next-generation RNA therapeutics for cancer, infectious diseases, and protein replacement therapies (Nature Reviews Drug Discovery, 2021).

Other names

Pattern recognition receptors for mRNA-LNPInnate immune sensors of mRNA vaccinesNucleic acid sensorsEndosomal and cytosolic RNA sensors

Drugs (primarily mRNA-LNP vaccines) interact with these receptors by providing ligands (single-stranded or double-stranded RNA) that trigger receptor dimerization and downstream signaling through adapter proteins like MyD88 or TRIF, leading to the production of Type I interferons and pro-inflammatory cytokines to enhance vaccine immunogenicity.